Clinical Trials: Why Diversity Matters
Everyone knows someone who has been diagnosed with cancer. Currently, only 4 percent of people who participate in a clinical trial are Black and 5 percent are Hispanic. Equal representation in medical research, treatment and prevention options is important. Your voice is valued; your health is personal.
If you or a loved one has cancer, understand your treatment options. Clinical trials are an essential element in The University of Kansas Cancer Center’s mission to conquer all cancers. Clinical trials lead to new ways to prevent, detect or treat cancer.
Sometimes, participating in a clinical trial will allow a patient to access a new treatment that may not be available to other patients. Participating in a clinical trial will help future patients. In addition to cancer treatment trials, The University of Kansas Cancer Center offers clinical trials designed to identify safer and more effective approaches to prevention, screening, diagnosis and cancer survivorship. By including people from a variety of backgrounds, clinical trials can show if the treatments are safe and work for different people.
The more I learned about different treatment options I had, it helped to squash the fears... Clinical Trial Participant
Find a Clinical Trial
This individual participated in a clinical trial of an investigational treatment. Clinical trials are different from standard medical care. As with all research studies, clinical trial participant outcomes vary. Before participating in a clinical trial, it is important to discuss the risks and benefits with your healthcare provider.